60dfrn

jspears on DSK121TN23PROD with NOTICES1

Federal Register / Vol. 87, No. 80 / Tuesday, April 26, 2022 / Notices
3. Australian Patent 2010241864,
issued June 5, 2014 (E–170–2009–0–
AU–03);
4. Canadian Patent 2,760,446, issued
January 2, 2018 (E–170–2009–0–CA–
04).
5. European Patent 2424887, issued
September 30, 2015 (E–170–2009–0–
EP–05); and a. Validated in DE, FR and
GB
6. United States Patent 8,556,882,
issued October 15, 2013 (E–170–2009–
0–US–06).
The patent rights in these inventions
have been assigned and/or exclusively
licensed to the government of the
United States of America.
The prospective exclusive license
territory may be worldwide, and the
field of use may be limited to the
following:
‘‘The use of the Licensed Patent
Rights to develop, manufacture,
distribute, sell, and use autologous
tumor infiltrating lymphocyte (TIL)
adoptive cell therapy products for the
treatment of cancer. Specifically
excluded from this Licensed Field of
Use are adoptive cell therapy products
genetically engineered to express a
chimeric antigen receptor and/or T cell
receptor.’’
E–170–2009 is primarily directed to
recombinant constructs for the
inducible expression of Interleukin-12
(IL–12). IL–12 has been reported to be
an important immunostimulatory
cytokine; however, its clinical utility
has been constrained, in part, by doselimiting toxicity following systemic
administration. The subject invention
potentially addresses this limitation by
operatively associating a nuclear factor
of activated T cells (NFAT) promoter
with the coding sequence for IL–12. TIL
engineered to express these constructs
produce and secrete IL–12 at the site of
antigen binding (exempli gratia, in the
tumor microenvironment).
This Notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective exclusive license will
be royalty bearing, and the prospective
exclusive license may be granted unless
within fifteen (15) days from the date of
this published Notice, the National
Cancer Institute receives written
evidence and argument establishing that
the grant of the license would not be
consistent with the requirements of 35
U.S.C. 209 and 37 CFR part 404.
In response to this Notice, the public
may file comments or objections.
Comments and objections, other than
those in the form of a license
application, will not be treated
confidentially and may be made
publicly available.

VerDate Sep<11>2014

18:45 Apr 25, 2022

Jkt 256001

License applications submitted in
response to this Notice will be
presumed to contain business
confidential information and any release
of information from these license
applications will be made only as
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
Dated: April 20, 2022.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2022–08795 Filed 4–25–22; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Immigration and Customs
Enforcement
[OMB Control Number 1653–0026]

Agency Information Collection
Activities; Extension of a Currently
Approved Collection: Information
Relating to Beneficiary of Private Bill
U.S. Immigration and Customs
Enforcement, Department of Homeland
Security.
ACTION: 60-Day notice.
AGENCY:

In accordance with the
Paperwork Reduction Act (PRA) of
1995, the Department of Homeland
Security (DHS), U.S. Immigration and
Customs Enforcement (ICE) will submit
the following Information Collection
Request (ICR) to the Office of
Management and Budget (OMB) for
review and clearance.
DATES: Comments are encouraged and
will be accepted until June 27, 2022.
ADDRESSES: All submissions received
must include the OMB Control Number
1653–0026 in the body of the
correspondence, the agency name and
Docket ID ICEB–2006–0015. All
comments received will be posted
without change to http://
www.regulations.gov, including any
personal information provided. Submit
comments via the Federal eRulemaking
Portal website at http://
www.regulations.gov under e-Docket ID
number ICEB–2006–0015.
FOR FURTHER INFORMATION CONTACT: If
you have questions related to this
revision, please contact: Ina Farka, ERO
Policy Unit, (202) 732–3270, eropolicy@
ice.dhs.gov. (This is not a toll-free
number. Comments are not accepted via
telephone message).
SUPPLEMENTARY INFORMATION:
SUMMARY:

PO 00000

Frm 00059

Fmt 4703

Sfmt 9990

24571

Comment
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a Currently Approved
Collection.
(2) Title of the Form/Collection:
Information Relating to Beneficiary of
Private Bill.
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: G–79A; U.S.
Immigration and Customs Enforcement.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State, Local, or Tribal
Government. This form is used by ICE
to obtain information from beneficiaries
and/or interested parties in Private Bill
cases when requested to report by the
Committee on the Judiciary.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 100 responses at 60 minutes (1
hour) per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total estimated annual
hour burden is 100 hours.
Dated: April 21, 2022.
Scott Elmore,
PRA Clearance Officer, U.S. Immigrations
and Customs Enforcement, Department of
Homeland Security.
[FR Doc. 2022–08856 Filed 4–25–22; 8:45 am]
BILLING CODE 9111–28–P

E:\FR\FM\26APN1.SGM

26APN1